Log Out

Enhabit (EHAB) Scheduled to Post Earnings on Tuesday

Defense World · Feb 7, 2023 03:32

Enhabit (NYSE:EHAB – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, February 14th. Analysts expect Enhabit to post earnings of $0.25 per share for the quarter. Individual that are interested in participating in the company's earnings conference call can do so using this link.

Enhabit Price Performance

Shares of NYSE:EHAB opened at $14.41 on Tuesday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.63. The firm's 50-day moving average is $13.89 and its two-hundred day moving average is $14.22. Enhabit has a 1 year low of $11.65 and a 1 year high of $25.25.

Get Enhabit alerts:

Insider Buying and Selling

In related news, Director Jeffrey Bolton purchased 2,000 shares of the firm's stock in a transaction that occurred on Wednesday, November 9th. The stock was purchased at an average cost of $12.75 per share, with a total value of $25,500.00. Following the completion of the acquisition, the director now directly owns 14,597 shares in the company, valued at $186,111.75. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.

Institutional Investors Weigh In On Enhabit

A number of hedge funds and other institutional investors have recently bought and sold shares of EHAB. Millennium Management LLC purchased a new position in shares of Enhabit in the second quarter valued at $230,000. Envestnet Asset Management Inc. purchased a new position in shares of Enhabit in the third quarter valued at $143,000. UBS Group AG increased its position in shares of Enhabit by 407,300.0% in the third quarter. UBS Group AG now owns 12,222 shares of the company's stock valued at $171,000 after buying an additional 12,219 shares in the last quarter. Macquarie Group Ltd. purchased a new position in shares of Enhabit in the third quarter valued at $187,000. Finally, Teachers Retirement System of The State of Kentucky purchased a new position in shares of Enhabit in the third quarter valued at $192,000. Institutional investors and hedge funds own 95.55% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on EHAB shares. CJS Securities started coverage on shares of Enhabit in a research note on Tuesday, December 13th. They set a "market perform" rating and a $18.00 target price on the stock. Stifel Nicolaus assumed coverage on shares of Enhabit in a research note on Monday, December 5th. They issued a "buy" rating and a $17.00 price target on the stock. Oppenheimer assumed coverage on shares of Enhabit in a research note on Thursday, October 13th. They issued a "market perform" rating on the stock. UBS Group assumed coverage on shares of Enhabit in a research note on Thursday, December 8th. They issued a "sell" rating and a $12.00 price target on the stock. Finally, Credit Suisse Group dropped their price target on shares of Enhabit from $19.00 to $15.00 and set a "neutral" rating on the stock in a research note on Friday, November 4th. Two analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $16.43.

About Enhabit

(Get Rating)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.